Skip to main content
. 2010 Nov-Dec;17(6):652–662. doi: 10.1136/jamia.2009.002477

Table 3.

Impact of data aggregation on drugs and conditions

PHARMetrics GE
Native Transformed Native Transformed
Total persons 32818355 10278445
Drug aggregation
 Total Drug Eras 718590080 309797580 231492741 96614637
 Eras per person 21.90 9.44 22.52 9.4
 Average exposure length 31 days 79 days NA 108 days
Rofecoxib
 Total persons 349929 186763
 Total rofecoxib Eras 1423273 510078 652234 264654
 Eras per person 4.07 1.46 3.49 1.42
 Average exposure length 34 days 99 days NA 102 days
Condition aggregation
 Total Condition Eras 3627194305 804977267 81693914 61795940
 Eras per person 110.52 24.53 7.95 6.01
 Average Condition Era length NA 6 days NA 88 days
Acute myocardial infarction (AMI)
 Total persons 221437 53063
 Total AMI Eras 5547711 292980 85940 53290
 AMI Eras per person 25.05 1.32 1.62 1.00
 Average Condition Era length NA 11 days NA 175 days